Trial · NCT05330130
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
NCT05330130, Phase 1, Completed, ART Fertility Clinics LLC
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells. Trials, record NCT05330130. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05330130
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
- NCT number
- NCT05330130
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 6 participants, actual
- Lead sponsor
- ART Fertility Clinics LLC
- Conditions
- Ovarian Function Insufficiency, Fertility Issues, Infertility,Female, Infertility
- Interventions
- Follitropin beta injection 150 IU, Follitropin beta injection 300 IU
- First posted
- 2022-04-15
- Last updated
- 2025-01-09
Source ClinicalTrials.gov
Registered outcomes36
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of FSHR- and LHR of the GC, obtained from one follicle on the morning of day 5, before the administration of the first GnRH-antagonist, punctured during the ovarian stimulation cycle | 5 days | |
| Primary | Number of FSHR- and LHR of the GC, obtained from tone follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm, punctured during the ovarian stimulation cycle | 1 day | |
| Primary | Number of FSHR- and LHR of the GC, obtained from two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation, punctured during the ovarian stimulation cycle | 1 day | |
| Primary | Number of FSHR- and LHR of the GC, obtained from the follicular fluid of follicles aspirated during OPU | 1 day | |
| Secondary | Level of E2 hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist | 5 days | |
| Secondary | Level of P4 hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist | 5 days | |
| Secondary | Level of FSH hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist | 5 days | |
| Secondary | Level of LH hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist | 5 days | |
| Secondary | Level of E2 hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm | 1 day | |
| Secondary | Level of P4 hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm | 1 day |
1 to 10 of 36Source ClinicalTrials.gov
See all 36 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers19
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05330130
GET https://conductscience.org/api/trials/v1/NCT05330130/registered?page=2